Effects of transcutaneous electrical nerve stimulation and instrument-assisted soft tissue mobilization combined treatment on chronic low back pain: A randomized controlled trial.

Journal of Back and Musculoskeletal Rehabilitation
Young Kyun KimKun Ho Lee

Abstract

Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain (CLBP) requires a treatment period of ⩾ 6 weeks to decrease pain and disability and is ineffective as sole treatment. Instrument-assisted soft tissue mobilization (IASTM) has rapid effects in musculoskeletal disorders. This study aimed to investigate the effects of a 3-week combined TENS and IASTM treatment (TICT) on CLBP. Thirty-two young men with CLBP were randomly divided into the TICT and control groups (n= 16 each). Patients were evaluated with the visual analog (VAS) and face pain-rating scales (FPRS) for pain, the Oswestry Disability Index (ODI) and passive straight leg raise (PSLR) test for flexibility, and the supine bridge test (SBT) for endurance before and after the treatment course. The TICT group received TICT on the lower back, glutes, and hamstrings, six times in 3 weeks. Group, time, and group × time interaction effects on pain were significant (VAS and FPRS, all p< 0.001). Group × time interaction (ODI, p< 0.001; PSLR, p< 0.05; SBT, p< 0.01) and group (ODI, p< 0.05) and time main effects (ODI, p< 0.001; PSLR, p< 0.01; SBT, p< 0.001) on motor function were significant. Thus, short-term TICT decreased pain level and increased motor func...Continue Reading

References

Nov 19, 1965·Science·R Melzack, P D Wall
Apr 1, 1996·Scandinavian Journal of Medicine & Science in Sports·E Mälkiä, A E Ljunggren
Sep 2, 1999·Lancet·G B Andersson
Nov 14, 2000·Spine·J C Fairbank, P B Pynsent
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Kathleen A Sluka, Deirdre Walsh
Jan 17, 2007·Journal of Manipulative and Physiological Therapeutics·Jeanmarie BurkeJ Donald Dishman
Feb 17, 2007·American Journal of Physical Medicine & Rehabilitation·Kerri L SchellenbergRobert S Burnham
Jan 24, 2009·Complementary Therapies in Clinical Practice·Kazunori ItohHiroshi Kitakoji
Feb 11, 2009·Archives of Internal Medicine·Janet K FreburgerTimothy S Carey
Sep 15, 2009·Journal of Manipulative and Physiological Therapeutics·James W BrantinghamFelix T Lee
Dec 17, 2009·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Gregory GarraHenry C Thode
Feb 1, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Maximilian BraunAndreas Michalsen
Feb 22, 2011·Journal of Manipulative and Physiological Therapeutics·Marc-André Blanchette, Martin C Normand
Feb 18, 2012·European Journal of Pain : EJP·A BuchmullerUNKNOWN Lombotens Trial Group
Dec 10, 2013·Best Practice & Research. Clinical Rheumatology·Rachelle BuchbinderDamian G Hoy
May 17, 2014·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Claudio Franceschi, Judith Campisi
Nov 14, 2014·Journal of Back and Musculoskeletal Rehabilitation·Mohsen RostamiRamin Kordi
Nov 15, 2014·Neuromodulation : Journal of the International Neuromodulation Society·Joshua Wellington
Jul 9, 2016·Journal of Physical Therapy Science·Jeong-Hoon LeeJae-Seop Oh
Jan 8, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Joanna RajfurJakub Taradaj
Feb 3, 2018·Regional Anesthesia and Pain Medicine·Lien-Chen WuChang-Jung Chiang
Feb 5, 2019·Complementary Therapies in Clinical Practice·Felix J SahaHolger Cramer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.